title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
"The Evolving Market Dynamics of B-cell Lymphomas: Diffuse Large B-cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Marginal Zone Lymphoma, Waldenstrom Macroglobulinemia, and Burkitt Lymphoma | DelveInsight",20231122T220100,https://www.prnewswire.com/news-releases/the-evolving-market-dynamics-of-b-cell-lymphomas-diffuse-large-b-cell-lymphoma-follicular-lymphoma-chronic-lymphocytic-leukemia-mantle-cell-lymphoma-marginal-zone-lymphoma-waldenstrom-macroglobulinemia-and-burkitt-lymphoma--301995626.html,RVMD,0.013173,Neutral,-0.019011
"Small-Cell Lung Cancer Market to Accelerate Substantially During the Study Period  ( 2019-2032 ) , Assesses DelveInsight | Leading Companies - Amgen, Novartis, AbbVie, BMS, Clovis Oncology, Cardiff Oncology, Roche, Daiichi Sankyo",20231004T210100,https://www.prnewswire.com/news-releases/small-cell-lung-cancer-market-to-accelerate-substantially-during-the-study-period-20192032-assesses-delveinsight--leading-companies----amgen-novartis-abbvie-bms-clovis-oncology-cardiff-oncology-roche-daiichi-sankyo-301946615.html,RVMD,0.043539,Neutral,-0.058975
Why Ascent Solar Technologies Shares Are Trading Lower By Around 50%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session - Ascent Solar Technologies  ( NASDAQ:ASTI ) ,20240410T180705,https://www.benzinga.com/news/24/04/38189280/why-ascent-solar-technologies-shares-are-trading-lower-by-around-50-here-are-other-stocks-moving-in,RVMD,0.094576,Neutral,0.0
Why Aaron's Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session,20230801T190537,https://markets.businessinsider.com/news/stocks/why-aaron-s-shares-are-trading-lower-by-over-9-here-are-other-stocks-moving-in-tuesday-s-mid-day-session-1032502331,RVMD,0.065866,Somewhat-Bullish,0.238806
"Earnings Scheduled For May 9, 2022",20220509T085247,https://www.benzinga.com/news/earnings/22/05/27068359/earnings-scheduled-for-may-9-2022,RVMD,0.019128,Neutral,-0.018433
"Revolution Medicines Advances First RAS ( ON )  Inhibitor into Clinic, Dosing First Patient in Phase 1/1b Trial of RMC-6236",20220628T110000,https://www.globenewswire.com/news-release/2022/06/28/2470203/0/en/Revolution-Medicines-Advances-First-RAS-ON-Inhibitor-into-Clinic-Dosing-First-Patient-in-Phase-1-1b-Trial-of-RMC-6236.html,RVMD,0.412887,Neutral,0.036366
"Chefs' Warehouse, Chart Industries And Some Other Big Stocks Moving Lower On Thursday - Cano Health  ( NYSE:CANO ) , The Chefs' Warehouse  ( NASDAQ:CHEF ) ",20221208T160409,https://www.benzinga.com/news/22/12/30009897/chefs-warehouse-chart-industries-and-some-other-big-stocks-moving-lower-on-thursday,RVMD,0.423843,Bearish,-0.399212
"Revolution Medicines, Inc.  ( RVMD )  Reports Q3 Loss, Lags Revenue Estimates",20231106T225005,https://www.zacks.com/stock/news/2179617/revolution-medicines-inc-rvmd-reports-q3-loss-lags-revenue-estimates,RVMD,0.397098,Neutral,0.010983
"Revolution Medicines, Inc.  ( RVMD )  Reports Q4 Loss, Tops Revenue Estimates",20230227T232506,https://www.zacks.com/stock/news/2059530/revolution-medicines-inc-rvmd-reports-q4-loss-tops-revenue-estimates,RVMD,0.399204,Neutral,0.100167
Molecular Glues Clinical Trial Pipeline Appears Robust With 10+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight,20240711T213100,https://www.prnewswire.com/news-releases/molecular-glues-clinical-trial-pipeline-appears-robust-with-10-key-pharma-companies-actively-working-in-the-therapeutics-segment--delveinsight-302194515.html,RVMD,0.074615,Neutral,0.082227
